Recent Announcements


CHX  Technologies has developed, patented, trialed and gained Canadian and European approvals for Prevora over 15 years, a period of development common to new drugs which are seeking a first-in-class therapeutic indication. CHX has also extensively researched and test marketed various marketing channels for Prevora. Recent announcements by CHX follow:


  • October 2017: CHX Technologies partners with MCI Medical Clinics on the integration of medical and oral healthcare services at a busy group practice in Toronto.


  • November 2016: CHX Technologies Partners with Ei A Pharmaceutical Solutionworks™ on the Manufacture of Prevora for the Canadian & European Market and for the Submission of Prevora’s New Drug Application to the US FDA






Click Links below for complete story.

This website is created and hosted by's Site Builder.